Back to Rankings

BLTE

Belite BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
BLTE vs peer average
40/100
BLTE vs. peer average (D vs. C)
Grade spread
A 1 · B 1 · C 3 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

SRPT is the first available peer comparator.

Rare-disease biotech; comparable on commercialization and regulatory execution risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerSRPTSarepta Therapeutics
BLTE
Belite Bio
SRPT
Sarepta Therapeutics
Grade
D
A
Momentum
33
22
Value
41
52
Sentiment
50
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs SRPT

BLTE / SRPT
Grade Position
Below peers
BLTE vs. peer average (D vs. C)
40/100
Momentum
33
BLTE
Value
41
SRPT
Sentiment
50
SRPT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BLTE
1
SRPT
SRPT
A
100/100
-3
2
EDIT
EDIT
B
80/100
-2
3
NTLA
NTLA
D
40/100
Even
4
XENE
Xenon Pharmaceuticals Inc Common
C
60/100
-1
5
CGON
CG Oncology Inc Common
C
60/100
-1
SRPT is the first peer returned for this comparison set.